Moonshots with Peter Diamandis

EP #147 Leading Stem Cell Expert: Stem Cells 101 - The Future of Medicine w/ Robert Hariri

Written by Peter H. Diamandis | Feb 10, 2025 5:32:10 AM

In this episode, Bob and Peter discuss Stem Cells 101, why it’s not available in America, and the importance of stem cell treatment for humanity. 

Recorded on Nov 21st, 2024

Views are my own thoughts; not Financial, Medical, or Legal Advice.

YOU WILL LEARN ABOUT

Dr. Robert Hariri is the Chairman, Founder, and CEO of Celularity, Inc., a leader in human cellular therapeutics developing placental stem cell-based therapies for cancer, autoimmune diseases, and other conditions. A distinguished surgeon, scientist, and entrepreneur, Dr. Hariri is known for discovering pluripotent stem cells from the human placenta and holds over 170 patents in the field. He founded Anthogenesis Corporation, later acquired by Celgene, and co-founded Human Longevity, Inc. Dr. Hariri, an MD and PhD graduate from Cornell University, serves as an Adjunct Professor of Neurosurgery at Weill Cornell Medical College and has earned prestigious honors, including the Pontifical Medal for Innovation and two Thomas Alva Edison Awards. His groundbreaking work continues to shape regenerative medicine and immuno-oncology. He’s also a founding partner of Fountain Life.

Learn more about Celularity: https://celularity.com/ 

Lifebank USA: https://www.lifebankusa.com/ 

Get my Longevity Guidebook here: https://qr.diamandis.com/book-audiopodcast

SPONSORS

I only endorse products and services I personally use. To see what they are, please support this podcast by checking out our sponsors: 

Get started with Fountain Life and become the CEO of your health: https://fountainlife.com/peter/

AI-powered precision diagnosis you NEED for a healthy gut: https://www.viome.com/peter 

Get 15% off OneSkin with the code PETER at  https://www.oneskin.co/ #oneskinpod

RESOURCES

I send weekly emails with the latest insights and trends on today’s and tomorrow’s exponential technologies. Stay ahead of the curve, and sign up now: Tech Blog